Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

Oct 18 - Markets closed

World markets

Shanghai 3,369.75 -12.04 (-0.36%)
Nikkei 225 21,503.85 +140.80 (0.66%)
Hang Seng Index 28,675.02 -36.74 (-0.13%)
TSEC 10,782.32 +62.04 (0.58%)
FTSE 100 7,542.87 +26.70 (0.36%)
EURO STOXX 50 3,619.65 +11.88 (0.33%)
CAC 40 5,383.81 +22.44 (0.42%)
S&P TSX 15,782.16 -34.74 (-0.22%)
S&P/ASX 200 5,896.30 +5.80 (0.10%)
BSE Sensex 32,584.35 0.00 (0.00%)
SMI 9,309.61 +39.75 (0.43%)
ATX 3,403.13 +29.99 (0.89%)
IBOVESPA 76,591.09 +389.84 (0.51%)
SET 1,710.17 +2.64 (0.15%)
BIST100 106,926.39 -64.48 (-0.06%)
IBEX 10,273.40 +56.60 (0.55%)
WIG 64,474.44 -379.71 (-0.59%)
TASI 6,941.78 -50.52 (-0.72%)
MERVAL 26,213.15 -409.29 (-1.54%)
IPC 49,938.98 -201.54 (-0.40%)
IDX Composite 5,928.11 -1.10 (-0.02%)

Currencies

EUR/USD 1.1800 +0.0004 (0.03%)
USD/JPY 112.9655 -0.0490 (-0.04%)
GBP/USD 1.3212 0.0000 (0.00%)
USD/CAD 1.2468 +0.0002 (0.02%)
USD/HKD 7.8041 -0.0040 (-0.05%)
USD/CNY 6.6317 +0.0112 (0.17%)
AUD/USD 0.7850 +0.0007 (0.09%)

Bonds

3 Month 1.03% 0.00 (0.00%)
6 Month 1.20% -0.01 (-0.83%)
2 Year 1.57% +0.01 (0.64%)
5 Year 2.00% +0.01 (0.50%)
10 Year 2.34% 0.00 (0.00%)
30 Year 2.85% +0.01 (0.35%)
US FDA approves Gilead cancer gene therapy; price set at $373000
(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.
A cancer treatment that's part of 'a big new field of medicine' just got approved  
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi ...  
Market Chart
23,157.60 +160.16 (0.70%)
2,561.26 +1.90 (0.07%)
6,624.22 +0.56 (0.01%)

Top stories

The company has now recalled more than 5 million vehicles for varying door latch-related issues since 2016. Reuters. WASHINGTON (Reuters) - Ford Motor Co said on Wednesday it would recall about 1.3 million 2015-17 Ford F-150 and 2017 Ford Super ...
American Express Co.'s Ken Chenault is (finally, some would say) retiring. The timing isn't bad. Saving Face. Ken Chenault's legacy has been saved in part by the rally in U.S.
Vegetables from a Blue Apron Holdings Inc. meal-kit delivery are arranged for a photograph in Tiskilwa, Ill. on June 14, 2017. Dan Acker—Bloomberg/Getty Images.
SeaWorld, which has struggled with declining attendance, announced it is cutting 350 positions effective today, a spokeswoman said Wednesday.
The former GE CEO used to have an empty private plane follow his own on trips, the Wall Street Journal's Thomas Gryta and Joann S. Lublin report in a story about the new CEO's cost cutting efforts.

Trends

Popular searches on GoogleChange Mkt Cap
FRO Frontline Ltd. 0.64% 8.51B

Sector summary

Sector Change % down / up
Energy -0.48%
Basic Materials -0.51%
Industrials +0.25%
Cyclical Cons. Goods ... +0.12%
Non-Cyclical Cons. Goods... +0.33%
Financials +0.37%
Healthcare -0.06%
Technology +0.23%
Telecommunications Servi... -0.34%
Utilities -0.23%